Therapy related acute myeloid leukemia and myelodysplastic syndrome
ORPHA:86846Acute myeloid leukaemia with myelodysplasia-related features
ORPHA:86845Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent
ORPHA:102379Acute myeloid leukemia and myelodysplastic syndromes related to radiation
ORPHA:164726Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor
ORPHA:102381Alpha-thalassemia-myelodysplastic syndrome
ORPHA:231401B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome
ORPHA:536467B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome
ORPHA:75496EEC syndrome and related disorders
ORPHA:98609Middle aortic syndrome
ORPHA:1456Myelodysplastic neoplasm with increased blasts
ORPHA:86839Myelodysplastic neoplasm with increased blasts type 1
ORPHA:100019Myelodysplastic neoplasm with increased blasts type 2
ORPHA:100020Myelodysplastic neoplasm with low blasts
ORPHA:98826Myelodysplastic syndrome
ORPHA:52688Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality
ORPHA:86841Myelodysplastic/myeloproliferative disease
ORPHA:98275MYH9-related syndromic thrombocytopenia
ORPHA:182050Noonan syndrome and Noonan-related syndrome
ORPHA:98733Orofacial clefting-cardiac anomalies-facial dysmorphism syndrome
ORPHA:660021SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome
ORPHA:157965Unclassified myelodysplastic syndrome
ORPHA:98827Unclassified myelodysplastic/myeloproliferative disease
ORPHA:98825